Patients in insulin analogues use via judicial litigation: do they use the Brazilian Public Health System (SUS)?
Abstract Background Studies show that among the drugs most commonly used in judicial litigation in Brazil, are those used to treat diabetes mellitus, especially insulin analogues. Objective Evaluate the use of the Unified Health System (SUS) by patients with type 1 diabetes mellitus (T1DM), who re...
Main Authors: | Thays Santos Mendonça, Eduardo Sérgio Silva, Mariana Linhares Pereira, Paulo Roque Obreli-Neto, Vinícius Silva Belo, Gustavo Costa Ferreira, Paula Resende Daher Chaves, Silvana Nair Leite, André Oliveira Baldoni |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto de Estudos em Saúde Coletiva da Universidade Federal do Rio de Janeiro
2023-05-01
|
Series: | Cadernos de Saúde Coletiva |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1414-462X2023000200202&lng=en&tlng=en |
Similar Items
-
Pharmacotherapeutic follow-up in patients with type 1 diabetes in context of judicialization: possibility optimize costs
by: William Neves Oliveira, et al.
Published: (2023-11-01) -
Ações judiciais e incorporação de medicamentos ao SUS: a atuação da Conitec
by: Kleize Araújo de Oliveira Souza, et al. -
Analysis of information on mitigating SUS's judicialization in digital media
by: Fernanda Rodrigues de Siqueira, et al.
Published: (2022-11-01) -
Judicialization and right to health in Brazil: a trajectory of matches and mismatches
by: Fabiola Sulpino Vieira
Published: (2023-02-01) -
Public Health System in Brazil nowadays: challenges for its operation and funding
by: Alethele de Oliveira Santos, et al.
Published: (2016-09-01)